drugset / Trial / NCT02434497
A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety of Rosuvastatin in Children and Adolescents with Homozygous Familial Hypercholesterolemia.
Timeline
- Start
- 2015-06-06
- Primary completion
- 2016-11-17
- Completion
- 2016-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 40 mg | Oral |